Scientists at the Johns Hopkins Kimmel Cancer Center found consistent epigenetic "signatures" across all metastatic tumors, in a genome-wide analysis of 13 metastatic prostate cancers patients. The discovery of the stable, epigenetic "marks" that sit on the nuclear DNA of cancer cells and alter gene expression, defies a prevailing belief that the marks vary so much within each individual's widespread cancers that they have little or no value as targets for therapy ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment